卡瑞利珠单抗联合GLF方案治疗晚期食管癌的效果
[关键词]食管肿瘤;免疫检查点抑制剂;抗肿瘤联合化疗方案;生物标记,肿瘤;自然杀伤T细胞;治疗结果[中图分类号]R735.1;R979.5 [文献标志码]A [文章编号] 2096-5532(2025)03-0426-05doi:10.11712/jms.2096-5532.2025.61.088 [开放科学(资源服务)标识码(OSID)][网络出版]https://link.cnki.net/urlid/37.1517.R.20250722.1341.004; 2025-07-2215:37:42Clinical efectofcamrelizumabcombined withtheGLFregimen in treatmentof advanced esophagealcancerTAOYan,LIShuang liang,YIN Shushan,YANGTian(DepartmentofOncology,Gaoping DistrictPeople'sHospital,Nanchong City,Nanchong 637100,China)
[Abstract]ObjectiveToinvestigatetheclinicalefectofcamrelizumabcombinedwiththeGLFregimeninthetreatmentof advancedesophagealcanceranditsefectontheexpresionofrelated tumormarkers.MethodsAtotalof96patientswithadvanced esophagealcancerwho wereadmitedtoGaoping District People's Hospitalfrom January2022 toOctober2023wereenroled as subjects,andtheywere dividedintocontrol groupand treatmentgroupusingthesimplerandom grouping method,with 48 patients ineach group.ThepatientsinthecontrolgroupreceivedtheGLFchemoradiotherapyregimen,andthoseinthetreatment groupreceivedcamrelizumabcombinedwiththeGLFregimen.Thetwo groups werecomparedintermsofclinicaloutcome ......
您现在查看是摘要页,全文长 20151 字符。